
Sarah A. Thurman MD
Clinical Instructor in Radiation Oncology, Massachusetts General Hospital
Join to View Full Profile
200 1st St SWRochester, MN 55905
Phone+1 507-422-6767
Are you Dr. Thurman?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Sarah Thurman, MD is a radiation oncologist in Rochester, Minnesota. She is currently licensed to practice medicine in Minnesota, Nebraska, and Nebraska. She is a Clinical Instructor in Radiation Oncology at Massachusetts General Hospital.
Education & Training
- Johns Hopkins UniversityResidency, Radiation Oncology, 1997 - 2001
- Carilion Clinic-Virginia Tech Carilion School of MedicineInternship, Transitional Year, 1996 - 1997
- University of Virginia School of MedicineClass of 1996
Certifications & Licensure
- MA State Medical License 2001 - 2026
- ME State Medical License 2004 - 2026
- MN State Medical License 2022 - 2026
- NE State Medical License 2021 - 2026
- NE State Medical License 2021 - 2026
- VA State Medical License 2020 - 2026
- NH State Medical License 2011 - 2025
- American Board of Radiology Radiation Oncology
- Join now to see all
Publications & Presentations
PubMed
- 37 citationsOutcome after breast-conserving therapy for patients with stage I or II mucinous, medullary, or tubular breast carcinomaSarah A Thurman, Stuart J. Schnitt, James L. Connolly, Rebecca Gelman, Barbara Silver
International Journal of Radiation Oncology, Biology, Physics. 2004-05-01 - 19 citationsThymoma and multiple malignancies: a case of five synchronous neoplasms and literature review.James S. Welsh, Sarah A. Thurman, Steven P. Howard
Clinical Medicine & Research. 2003-07-01 - 3 citationsSm-153 EDTMP for recurrent metastatic osteosarcoma.James S. Welsh, Sarah A. Thurman, Scott Borzillary, Cindy L. Schwartz, Steven P. Howard
Clinical Advances in Hematology & Oncology. 2003-03-01